Asia Pacific transcriptomics market will grow by 13.1% annually with a total addressable market cap of $ 29,787.1 million over 2022-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.
Highlighted with 39 tables and 46 figures, this 120-page report “Asia Pacific Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.
Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
• Services
Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Component 41
3.1 Market Overview by Component 41
3.2 Instruments 43
3.3 Consumables 45
3.4 Software 47
3.5 Services 49
4 Segmentation of Asia Pacific Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Polymerase Chain Reaction (PCR) 52
4.3 Next-Generation Sequencing 54
4.4 Microarray 56
4.5 In-Situ Hybridization (ISH) 58
4.6 Gene Regulation Technologies 60
4.7 Other Technologies 61
5 Segmentation of Asia Pacific Market by Application 62
5.1 Market Overview by Application 62
5.2 Drug Discovery and Development 64
5.3 Diagnostics 65
5.4 Single Cell Analysis 66
5.5 Gene Expression 67
5.6 Cell Biology 68
5.7 Other Applications 69
6 Segmentation of Asia Pacific Market by End User 70
6.1 Market Overview by End User 70
6.2 Academic and Research Institutions 72
6.3 Biotechnology and Biopharmaceutical Companies 73
6.4 Contract Research Organizations (CROs) 74
6.5 Other End Users 75
7 Asia-Pacific Market 2021-2031 by Country 76
7.1 Overview of Asia-Pacific Market 76
7.2 Japan 79
7.3 China 82
7.4 Australia 84
7.5 India 86
7.6 South Korea 88
7.7 Rest of APAC Region 90
8 Competitive Landscape 92
8.1 Overview of Key Vendors 92
8.2 New Product Launch, Partnership, Investment, and M&A 97
8.3 Company Profiles 98
10x Genomics 98
Agilent Technologies, Inc. 100
ANGLE plc 101
Becton, Dickinson and Company (BD) 102
Bio-Rad Laboratories, Inc. 103
BioSypder, Inc. 104
Bio-Techne 105
Cytiva 106
F. Hoffmann-La Roche Ltd. 107
Fluidigm Corporation 108
GE Healthcare 109
Illumina, Inc. 110
Menarini Silicon Biosystems 111
Merck & Co., Inc. 112
NanoString 113
Pacific Biosciences of California, Inc. 114
PerkinElmer Inc. 115
Promega Corporation 116
Qiagen N. V. 117
Takara Bio Inc. 118
Thermo Fisher Scientific Inc. 119
RELATED REPORTS 120
List of Tables:
Table 1. Snapshot of Asia Pacific Transcriptomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Transcriptome Databases 28
Table 4. World Personalized Medicine Market, 2021-2031, $ bn 29
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Transcriptomics Market 33
Table 6. Asia Pacific Transcriptomics Market by Component, 2021-2031, $ mn 41
Table 7. Main Instrument Products from Key Vendors 44
Table 8. Main Consumable Products from Key Vendors 46
Table 9. Main Software Products from Key Vendors 48
Table 10. Asia Pacific Transcriptomics Market by Technology, 2021-2031, $ mn 50
Table 11. Main PCR-based Transcriptomics and Key Vendors 53
Table 12. Main NGS-based Transcriptomics and Key Vendors 55
Table 13. Main Microarray-based Transcriptomics and Key Vendors 57
Table 14. Main ISH-based Transcriptomics and Key Vendors 59
Table 15. Asia Pacific Transcriptomics Market by Application, 2021-2031, $ mn 62
Table 16. Asia Pacific Transcriptomics Market by End User, 2021-2031, $ mn 70
Table 17. APAC Transcriptomics Market by Country, 2021-2031, $ mn 77
Table 18. Japan Transcriptomics Market by Component, 2021-2031, $ mn 81
Table 19. Japan Transcriptomics Market by Technology, 2021-2031, $ mn 81
Table 20. Japan Transcriptomics Market by Application, 2021-2031, $ mn 81
Table 21. China Transcriptomics Market by Component, 2021-2031, $ mn 83
Table 22. China Transcriptomics Market by Technology, 2021-2031, $ mn 83
Table 23. China Transcriptomics Market by Application, 2021-2031, $ mn 83
Table 24. Australia Transcriptomics Market by Component, 2021-2031, $ mn 85
Table 25. Australia Transcriptomics Market by Technology, 2021-2031, $ mn 85
Table 26. Australia Transcriptomics Market by Application, 2021-2031, $ mn 85
Table 27. India Transcriptomics Market by Component, 2021-2031, $ mn 87
Table 28. India Transcriptomics Market by Technology, 2021-2031, $ mn 87
Table 29. India Transcriptomics Market by Application, 2021-2031, $ mn 87
Table 30. South Korea Transcriptomics Market by Component, 2021-2031, $ mn 89
Table 31. South Korea Transcriptomics Market by Technology, 2021-2031, $ mn 89
Table 32. South Korea Transcriptomics Market by Application, 2021-2031, $ mn 89
Table 33. Transcriptomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 91
Table 34. Transcriptomic Products Approved by FDA 94
Table 35. Sequencing Technology Platforms for RNA-Sequencing 95
Table 36. RNA-Sequencing De Novo Assembly Software 95
Table 37. 10x Genomics: Company Snapshot 98
Table 38. 10x Genomics: Business Segmentation 99
Table 39. 10x Genomics: Product Portfolio 99
